Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Qinlock (ripretinib)
i
Other names:
DCC-2618, DCC 2618, DCC2618
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(11)
News
Trials
Company:
GENESIS Pharma, Ono Pharma, Specialised Therap, ZAI Lab
Drug class:
c-KIT inhibitor, FLT3 inhibitor, PDGFR α inhibitor
Related drugs:
‹
dasatinib (215)
imatinib (166)
sunitinib (139)
lenvatinib (90)
YD312 (21)
MLN518 (8)
SU5614 (6)
pexidartinib (6)
flumatinib (5)
ABT-869 (2)
AG-1296 (1)
IDRX-42 (1)
OSI-930 (1)
MP470 (1)
PLX9486 (1)
CS 2164 (1)
E7050 (1)
CDX-0158 (0)
M4205 (0)
NB003 (0)
NMS-088 (0)
JSP191 (0)
AER-901 (0)
TSU-68 (0)
BAY 57- 9352 (0)
PTK787 (0)
quizartinib (40)
ARO-002 (25)
PHI-101 (12)
CA-4948 (6)
CG-806 (6)
AST-487 (5)
CB-659 (4)
FF-10101 (3)
pacritinib (3)
CEP-701 (3)
BGS-2456 (2)
HPB-092 (2)
fedratinib (2)
JRF104 (2)
MEN1703 (2)
Max-40279 (2)
UNC2025 (2)
HEC73543 (2)
HM43239 (2)
TG02 (2)
AIU2008 (1)
CDDD11-8 (1)
D-65476 (1)
E6201 (1)
EC-70124 (1)
KC1036 (1)
KF-1601 (1)
KRC-108 (1)
PLD-102 (1)
STI-8591 (1)
XY0206 (1)
AM-5992 (0)
BMF-500 (0)
CCT137690 (0)
CLN-049 (0)
CTS2016 (0)
D-64406 (0)
EP0042 (0)
FLX925 (0)
FN-1501 (0)
4G8-SDIEM (0)
HYML-122 (0)
KW-2449 (0)
LT-171-861 (0)
MG-D-1509 (0)
MRX2843 (0)
R1530 (0)
RF-1302 (0)
SU 14813 (0)
SKI-G-801 (0)
flonoltinib (0)
SKLB-1028 (0)
MEDI-575 (0)
dasatinib (215)
imatinib (166)
sunitinib (139)
lenvatinib (90)
YD312 (21)
MLN518 (8)
SU5614 (6)
pexidartinib (6)
flumatinib (5)
ABT-869 (2)
AG-1296 (1)
IDRX-42 (1)
OSI-930 (1)
MP470 (1)
PLX9486 (1)
CS 2164 (1)
E7050 (1)
CDX-0158 (0)
M4205 (0)
NB003 (0)
NMS-088 (0)
JSP191 (0)
AER-901 (0)
TSU-68 (0)
BAY 57- 9352 (0)
PTK787 (0)
quizartinib (40)
ARO-002 (25)
PHI-101 (12)
CA-4948 (6)
CG-806 (6)
AST-487 (5)
CB-659 (4)
FF-10101 (3)
pacritinib (3)
CEP-701 (3)
BGS-2456 (2)
HPB-092 (2)
fedratinib (2)
JRF104 (2)
MEN1703 (2)
Max-40279 (2)
UNC2025 (2)
HEC73543 (2)
HM43239 (2)
TG02 (2)
AIU2008 (1)
CDDD11-8 (1)
D-65476 (1)
E6201 (1)
EC-70124 (1)
KC1036 (1)
KF-1601 (1)
KRC-108 (1)
PLD-102 (1)
STI-8591 (1)
XY0206 (1)
AM-5992 (0)
BMF-500 (0)
CCT137690 (0)
CLN-049 (0)
CTS2016 (0)
D-64406 (0)
EP0042 (0)
FLX925 (0)
FN-1501 (0)
4G8-SDIEM (0)
HYML-122 (0)
KW-2449 (0)
LT-171-861 (0)
MG-D-1509 (0)
MRX2843 (0)
R1530 (0)
RF-1302 (0)
SU 14813 (0)
SKI-G-801 (0)
flonoltinib (0)
SKLB-1028 (0)
MEDI-575 (0)
›
Associations
(11)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Gastrointestinal Stromal Tumor
No biomarker
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: A1 - Approval
ripretinib
Sensitive
:
A1
ripretinib
Sensitive: A1 - Approval
ripretinib
Sensitive
:
A1
PDGFRA exon 18 mutation
Gastrointestinal Stromal Tumor
PDGFRA exon 18 mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: A2 - Guideline
ripretinib
Sensitive
:
A2
ripretinib
Sensitive: A2 - Guideline
ripretinib
Sensitive
:
A2
KIT mutation
Gastrointestinal Stromal Tumor
KIT mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
PDGFRA mutation
Gastrointestinal Stromal Tumor
PDGFRA mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
KIT exon 17 mutation
Gastrointestinal Stromal Tumor
KIT exon 17 mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
KIT exon 13 mutation
Gastrointestinal Stromal Tumor
KIT exon 13 mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
KIT exon 9 mutation
Gastrointestinal Stromal Tumor
KIT exon 9 mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
KIT exon 11 mutation
Gastrointestinal Stromal Tumor
KIT exon 11 mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
KIT exon 18 mutation
Gastrointestinal Stromal Tumor
KIT exon 18 mutation
Gastrointestinal Stromal Tumor
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
ripretinib
Sensitive: B - Late Trials
ripretinib
Sensitive
:
B
KIT mutation
Melanoma
KIT mutation
Melanoma
ripretinib
Sensitive: C3 – Early Trials
ripretinib
Sensitive
:
C3
ripretinib
Sensitive: C3 – Early Trials
ripretinib
Sensitive
:
C3
KIT amplification
Melanoma
KIT amplification
Melanoma
ripretinib
Sensitive: C3 – Early Trials
ripretinib
Sensitive
:
C3
ripretinib
Sensitive: C3 – Early Trials
ripretinib
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login